Efficacy of oral directly acting antivirals in HIV/HCV co-infected patients with genotype 4 infection: A real world MADRID-CoRe study
Phase of Trial: Phase IV
Latest Information Update: 16 Feb 2017
At a glance
- Drugs Daclatasvir/sofosbuvir-Mylan-Laboratories (Primary) ; Ledipasvir/sofosbuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary) ; Simeprevir (Primary) ; Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 16 Feb 2017 Results (n=146) presented at the 24th Conference on Retroviruses and Opportunistic Infections.
- 04 Jan 2017 Status changed from not stated to completed.
- 04 Jan 2017 New trial record